Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.
about
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patientsCREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance.Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic SteatosisNew insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel.Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients.Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscleChildhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.Assessment of gut microbiota populations in lean and obese Zucker rats.Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism.Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway.Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model.Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease.Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS).Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis.Natural History of NAFLD/NASH.
P2860
Q29994538-129AB38C-4465-4970-93B9-83756E42FDEFQ33620848-D44D1D69-6942-4612-90E1-F7C584FA0AB9Q36154945-BD7AF60B-EB6C-4303-8BAA-AB7FFA018E72Q37035153-E29785FF-D320-4F76-A02C-EB5112280A17Q37040345-4530ADA4-C782-45B1-955E-47EB7931B750Q37578970-2C6E41E9-1A3A-4F77-B5E4-48DF713B6541Q37669343-106BC2DF-E7F9-4D46-AECD-AFBA9D162BCEQ37703491-591F8009-A2D0-4ADC-97FB-38EE5CC4A566Q38868400-91AB0D1F-698B-47C6-89FC-DBAF0C4D214CQ39410610-45D68EDD-0BF1-4FB8-A445-78EE32D84C20Q41007942-A29C3035-7B44-4343-AC18-1CF5E9D72D8AQ45072762-56BE85B8-EFF5-4F72-8AC5-66007F6D0B3EQ46494101-AEE12C55-651E-4CE0-BE78-861FA7D4D1F7Q47220544-C8B8EB6C-702E-4911-988D-B5C52456C1FEQ47608940-3D6E706C-5E80-407E-A98F-74B9C396EE65Q47845194-355D0C83-1001-4A33-AE06-0D02377CE8CFQ48192095-4840495D-4C06-4B20-9317-F7B817698662Q53688741-6B444B5E-BE49-42F8-AECA-6E71A62D21F3Q55003235-DF2BB2A5-4514-4BF1-B77B-433E2306249CQ55125188-502E5A4E-FA21-49D1-AF2A-4A3E0BC8A914Q55236886-747BB87B-8D1B-498F-BE63-111EE91DBFB1Q55514085-27C1D8E5-63BA-4F3B-B7A8-CBF1049B3CFC
P2860
Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Obesity is an independent risk ...... analysis of 21 cohort studies.
@en
type
label
Obesity is an independent risk ...... analysis of 21 cohort studies.
@en
prefLabel
Obesity is an independent risk ...... analysis of 21 cohort studies.
@en
P2093
P2860
P356
P1433
P1476
Obesity is an independent risk ...... analysis of 21 cohort studies.
@en
P2093
P2860
P304
P356
10.1111/OBR.12407
P577
2016-03-28T00:00:00Z